Elaine Chen1, Karen Homa2, Jessica Goggin3, Kathryn A Sabadosa4, Sarah Hempstead5, Bruce C Marshall5, Albert Faro5, Elisabeth P Dellon6. 1. Rush University Medical Center, Chicago, IL, United States. Electronic address: elaine_chen@rush.edu. 2. Independent Consultant, Orford, NH, United States. 3. University of California, San Diego, CA, United States. 4. The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States. 5. Cystic Fibrosis Foundation, Bethesda, MD, United States. 6. University of North Carolina School of Medicine, Chapel Hill, NC, United States.
Abstract
BACKGROUND: There are many challenges to providing end-of-life care (EOLC) to people with cystic fibrosis (CF). METHODS: Chart abstraction was used to examine EOLC in adults with CF who died between 2011 and 2013. RESULTS: We reviewed 248 deaths from 71 CF care centers. Median age at death was 29years (range 18-73). While median FEV1 was in the severe lung disease category (FEV1<40%), 38% had mild or moderate lung disease in the year preceding death. The most common location of death was the intensive care unit (ICU, 39%), and 12% of decedents were listed for lung transplant. Fewer of those dying in the ICU personally participated in advance care planning or utilized hospice or Palliative Care Services (p<0.05). CONCLUSIONS: Adults dying with CF in the United States most commonly die in an ICU, with limited and variable use of hospice and Palliative Care Services. Palliative care and advance care planning are recommended as a routine part of CF care.
BACKGROUND: There are many challenges to providing end-of-life care (EOLC) to people with cystic fibrosis (CF). METHODS: Chart abstraction was used to examine EOLC in adults with CF who died between 2011 and 2013. RESULTS: We reviewed 248 deaths from 71 CF care centers. Median age at death was 29years (range 18-73). While median FEV1 was in the severe lung disease category (FEV1<40%), 38% had mild or moderate lung disease in the year preceding death. The most common location of death was the intensive care unit (ICU, 39%), and 12% of decedents were listed for lung transplant. Fewer of those dying in the ICU personally participated in advance care planning or utilized hospice or Palliative Care Services (p<0.05). CONCLUSIONS: Adults dying with CF in the United States most commonly die in an ICU, with limited and variable use of hospice and Palliative Care Services. Palliative care and advance care planning are recommended as a routine part of CF care.
Authors: Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz Journal: J Cyst Fibros Date: 2019-03-27 Impact factor: 5.482
Authors: Elisabeth P Dellon; Melissa Basile; Mara R Hobler; Anna M Georgiopoulos; Elaine Chen; Jessica Goggin; Christopher H Goss; Sarah E Hempstead; Albert Faro; Dio Kavalieratos Journal: J Palliat Med Date: 2020-02-05 Impact factor: 2.947
Authors: Jane Lowers; Elisabeth P Dellon; Anne Stephenson; Robert Arnold; Andrew Althouse; Kwonho Jeong; Ethan Dubin; Jesse Soodalter; Cade Hovater; Marie Bakitas; Jessica Goggin; William Hunt; Sigrid Ladores; Kimberly Curseen; Gretchen Winter; George Solomon; Jonathan Ailon; Douglas Conrad; Dio Kavalieratos Journal: BMJ Open Respir Res Date: 2022-09
Authors: Elizabeth T Trandel; Joseph M Pilewski; Elisabeth P Dellon; Kwonho Jeong; Jonathan G Yabes; Laura T Moreines; Robert M Arnold; Zachariah P Hoydich; Dio Kavalieratos Journal: J Cyst Fibros Date: 2019-12-18 Impact factor: 5.482
Authors: Dio Kavalieratos; Anna M Georgiopoulos; Lara Dhingra; Melissa J Basile; Elliot Rabinowitz; Sarah E Hempstead; Albert Faro; Elisabeth P Dellon Journal: J Palliat Med Date: 2020-09-16 Impact factor: 2.947